'김갑성' 기자의 전체기사
-
Informal caregivers in Singapore seen as undertrained an…
Despite nearly all professional caregivers agreeing that informal caregivers can help bridge the demand of caregiving in Singapore to a certain extent (30% large, 45% moderate, 23% small extent), only a quarter of professionals (25%) say that informal caregivers today are "somewhat capable" of providing necessary care, with none believing they are "very capable". Around four in five (79%) professional caregivers say that informal caregivers are either "minimally trained" or not "trained at all" in caregiving; with all professionals agreeing
- 김갑성 기자
- 2025-07-25 12:57
-
Everest Medicines Announces Share Placement to Raise Ap…
SHANGHAI, July 25, 2025 -- Everest Medicines (HKEX 1952.HK, "Everest" or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that it has entered into a placing and subscription agreement with the placing agents and its controlling shareholder, CBC Group (the "Sellers"), for a top-up placement of 22,561,000 shares to raise approximately HK$1,572.50 million, representing approximately 6.87% of the total number of Shares in issue as at the date of
- 김갑성 기자
- 2025-07-25 10:30
-
Global Times: How to care for tens of thousands of seniors…
BEIJING, July 25, 2025 -- Life has never been happier for Xu Furong. The 86-year-old resident of Nanliuzhuang village starts each morning with a bit of light housework. Then, hand in hand with her 90-year-old husband, she walks for about 10 minutes, crossing two streets to reach the "senior canteen," which offers elderly residents convenient services at the "Yiyuanhong" Happy Home Livelihood Complex located just across from the village's Party committee office. During the heat of summer, the senior canteen offers a refreshing and comfortable haven. By around
- 김갑성 기자
- 2025-07-25 10:24
-
Leads Biolabs Lists on HKEX, Raising USD 189 Million Through…
NANJING, China, July 25, 2025 -- On 25 July, 2025 (China Time), Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company") listed on the Main Board of The Stock Exchange of Hong Kong Limited (HKEX) under the stock code "09887". The clinical-stage biotech company priced its IPO at HKD 35 per share, offering 36.86 million shares (excluding green shoe option). The deal included a Hong Kong public tranche of 16.03 million shares (43% of the total) and an international placement of 20.84 million shares (57%). Morgan Stanley and CITIC Securities acted as
- 김갑성 기자
- 2025-07-25 09:00
-
Colorcon Celebrates Grand Opening of New Manufacturing…
Johor plant is Colorcon's 7th major film coating plant and 16th manufacturing facility worldwide HARLEYSVILLE, Pa. and JOHOR, Malaysia, July 24, 2025 -- Colorcon, a global leader of film coating systems, specialty excipients, controlled release formulations and controlled atmosphere packaging for the pharmaceutical and nutraceutical industries, today announced the grand opening of a new, state-of-the-art film coating manufacturing facility in Johor Malaysia. The 200,000 square-foot facility will immediately employ 30 people and will serve as the production hub fo
- 김갑성 기자
- 2025-07-24 22:00
-
Angel Yeast Showcases Innovative Yeast Protein at 2025 IFT F…
CHICAGO, July 24, 2025 -- The 2025 IFT FIRST (Food Improved by Research, Science, and Technology), one of the world's largest food science and innovation expos, recently took place from July 13 to 16 in Chicago. At the expo, Angel Yeast (SHA:600298) showcased its comprehensive, innovative lineup of yeast protein, yeast extract and baking solutions, nutritional health ingredients and brewing technologies under the themes of "Yeast Extract-Enjoy a Flavorful Life" and "Yeast Protein-Redefining Future Proteins." Angel Yeast has especially promoted the in
- 김갑성 기자
- 2025-07-24 21:00
-
AMSC Malaysia 2025 Set to Spotlight World-Class Expertise and I…
KUALA LUMPUR, Malaysia, July 24, 2025 -- The Aesthetic Medicine & Surgery Conference & Exhibition (AMSC) returns for its fourth edition from August 6-7, 2025, with an expanded focus on global participation and advanced education. Held at the Kuala Lumpur Convention Centre (KLCC), AMSC 2025 will feature over 160 world-class speakers, 200 international brands, and 20 supporting partners, including 13 medical societies and 7 industry collaborators. More than 1,600 delegates from around the world are expected, with highlights including clinical innovation updates, live demonstrations, and
- 김갑성 기자
- 2025-07-24 20:24
-
OSR Holdings Enters into Term Sheet to Acquire Woori IO, a Pion…
BELLEVUE, Wash. and SEOUL, South Korea, July 24, 2025 -- OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company advancing biomedical and wellness innovation, today announced it has signed a term sheet ("Term Sheet") with Woori IO Co., Ltd. ("WORIO"), a South Korean medical device company developing next-generation noninvasive glucose monitoring technology. The agreement sets forth certain key terms for a strategic acquisition of WORIO by OSR Holdings' Korean affiliate, OSR Holdings Co., Ltd. ("OSRK"). Under the proposed struct
- 김갑성 기자
- 2025-07-24 19:30
-
OSR 홀딩스, 비침습형 혈당측정 분야 리더 우리아이오 인수 텀싯 체결
밸뷰, 미국 & 서울, 대한민국 2025년 7월 24일 -- 글로벌 바이오 메디컬 기술혁신을 선도하는 헬스케어 기업 OSR Holdings, Inc. (NASDAQ: OSRH)은 비침습형 혈당 측정 기술을 개발 중인 국내 의료장비 기업인 주식회사 우리아이오 ("우리아이오")와 인수를 위한 텀싯(Term Sheet)을 체결했다고 발표했습니다. 금번 텀싯을 바탕으로 향후 실사를 거쳐 본 계약의 체결시, OSR Holdings의 한국 자회사인 주식회사 오에스알홀딩스 ("OSRK")가 우리아이오를 포괄적 주식교환 방식으로 인수하여 완전 자회사로 편입할 예정입니다. 텀싯에 따라 예상되는 거래는 OSRK가 우리아이오의 기존 주주들에게 신주를 발행하고, 이들이 일정 조건 하에 해당 주식을 미국 나스닥 상장사인 OSRH의 보통주로 전환할 수 있도록 허용하는 구조입니다. 구체적으로, 우리아이오 주주들은 1 OSRK 주식을 12.96 OSRH 주식으로 전환할 수 있는 권리를 부여받게 되며, 이는 거래 종료일로부터 3년 이내에 OSRH 주가가 최소 1회 $10.00에 도
- 김갑성 기자
- 2025-07-24 19:30
-
Fapon at ADLM 2025: One-stop IVD Solutions & Deepened US C…
CHICAGO, July 24, 2025 -- Fapon, a global leader in life sciences, will unveil its innovative one-stop IVD solutions at ADLM 2025, from July 29 to 31 in Chicago, IL. Fapon aims to be the trusted global partner for laboratories and IVD manufacturers with advanced innovations and dedicated localization services for the North American market. Comprehensive and Customized IVD Solutions Fapon offers a wide range of high-performance raw materials, reagent services, and open-system instruments tailored for the North American market. At ADLM, Fapon will introduce t
- 김갑성 기자
- 2025-07-24 19:00
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 5아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 6하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 7대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2025-10-25_SAT
- PINTEC Announces Changes in the Board of Directors 04:30
- MindHYVE.ai™ and Prime Institute of Health Sciences (PIHS) Launch Landmark AI Partnership to Transform Education and Healthcare in Pakistan 02:18
- Freedom Engineered: QUINEAR QN-090A Redefines Smart, Cordless Recovery -- Just in Time for Holiday Season 00:10
- Beyond Recovery: QUINEAR QN-071A Brings Professional Compression Therapy Home for Holiday Deals 00:07
2025-10-24_FRI
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2025년 10월 25일 06시 00분